David Kramer: The first US production in 30 years of molybdenum-99, the parent isotope of the most widely used medical radioisotope, is expected to begin within weeks after federal regulators approved a manufacturing process developed by Wisconsin-based NorthStar Medical Radioisotopes. NorthStar received $25 million in matching funds from DOE for development of the neutron capture process and $14.8 million of an expected $25 million total for its accelerator approach.
Latest from John Shanahan
- Must/can the world abandon fossil fuels and go all nuclear in 3 decades or any time frame like that? (J Goldstein, S Qvist, J Shanahan) USofA
- Need for sound infrastructure management (G C T Mathibe, B Comby, J Shanahan) South Africa France USofA
- Ten reasons to exit the Paris climate change agreement (Viv Forbes) Australia
- Summary of 2018 ANS - HPS Joint Conference on Low Dose Radiation and LNT (Alan Waltar) USofA
- Follow the money on man-made climate change (Paul Driessen, CFACT) USofA